Medicine & Life Sciences

1. Neoplasms 100%
2. Barrett Esophagus 73%
3. Loss of Heterozygosity 70%
4. Comparative Genomic Hybridization 63%
5. Adenocarcinoma 59%
6. Genome 53%
7. Pancreatic Neoplasms 53%
8. Aneuploidy 50%
9. Triple Negative Breast Neoplasms 47%
10. Oligonucleotide Array Sequence Analysis 39%
11. Mutation 37%
12. Cholangiocarcinoma 34%
13. DNA 33%
14. gemcitabine 33%
15. Biliary Tract Neoplasms 32%
16. Population 29%
17. Genes 28%
18. Clonal Evolution 28%
19. Cisplatin 25%
20. Chromothripsis 25%
21. Genomic Instability 23%
22. Receptor, Fibroblast Growth Factor, Type 2 22%
23. Prostatic Neoplasms 21%
24. Tetraploidy 21%
25. Adenosquamous Carcinoma 21%
26. Breast Neoplasms 20%
27. Therapeutics 20%
28. Ploidies 20%
29. Diploidy 20%
30. Clone Cells 20%
31. Waldenstrom Macroglobulinemia 20%
32. NUC-1031 18%
33. Small Cell Carcinoma 18%
34. Heterografts 17%
35. Biopsy 17%
36. Epithelium 17%
37. Circulating Tumor DNA 17%
38. Chromosomes 16%
39. Pancreas 16%
40. Survival 16%
41. Cytogenetics 16%
42. Sarcoma 16%
43. Methylation 15%
44. Immunohistochemistry 15%
45. Formaldehyde 15%
46. Fluorescence In Situ Hybridization 15%
47. Vesiculovirus 15%
48. Phenotype 15%
49. Multiple Myeloma 14%
50. Cell Line 14%